Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos Pathogens|September 17, 2010
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodelingPriscille Brodin, Yannick Poquet, Florence Levillain, et al.Journal of Medicinal Chemistry|April 18, 2017
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary FibrosisNicolas Desroy, Christopher Housseman, Xavier Bock, et al.Journal of Medicinal Chemistry|September 28, 2021
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic DiseasesOscar Mammoliti, Koen Jansen, Sandy El Bkassiny, et al.Journal of Medicinal Chemistry|September 9, 2020
Discovery of 9-Cyclopropylethynyl-2-((<i>S</i>)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical TrialFrédéric Labéguère, Sonia Dupont, Luke Alvey, et al.Plos Pathogens|October 31, 2009
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitorsThierry Christophe, Mary Jackson, Hee Kyoung Jeon, et al.Journal of Medicinal Chemistry|November 8, 2014
Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinicMathieu Pizzonero, Sonia Dupont, Marielle Babel, et al.Journal of Medicinal Chemistry|July 22, 2017
Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin InhibitorsAgnès Joncour, Nicolas Desroy, Christopher Housseman, et al.Journal of Medicinal Chemistry|January 20, 2026
Discovery and Characterization of GLPG3808, a PAPD5/7 Inhibitor for Suppression of Hepatitis B Viral InfectionsOscar Mammoliti, Adeline Palisse, Ann De Blieck, et al.Science (New York, N.Y.)|March 21, 2009
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesisVadim Makarov, Giulia Manina, Katarina Mikusova, et al.Nature Medicine|August 6, 2013
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosisKevin Pethe, Pablo Bifani, Jichan Jang, et al.Pageof 3